Wednesday, August 26, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 3, 2026

OSB GROUP PLC - Transaction in Own Shares

View original at finance.yahoo.com
OSB GROUP PLC - Transaction in Own Shares OSB GROUP PLC OSB GROUP PLC ISIN: GB00BLDRH360 03 March 2026 LEI number: 213800ZBKL9BHSL2K459 OSB GROUP PLC (the “Company”) Transaction in Own Shares and completion of buyback The Company announces that on 02 March 2026 it had purchased a total of 85,851 of its ordinary shares…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Following settlement and cancellation of the purchased shares, the Company's total number of ordinary shares in issue shall be 352,661,050 ordinary shares with no shares held in treasury

    80% confidence

  • The share buy-back programme announced on 13 March 2025 has completed following the purchase of these shares

    80% confidence

Data points we hold from this source

OSB GROUP PLC · shares outstanding352661050 shares
OSB GROUP PLC · treasury shares0 shares
OSB GROUP PLC · voting rights352661050 shares
OSB GROUP PLC · buyback total value100000000 GBP
OSB GROUP PLC · buyback avg price527.94 GBp
OSB GROUP PLC · stock price604.50 GBp
OSB GROUP PLC · buyback total shares18937314 shares
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
OSB GROUP PLC - Transaction in Own Shares — Source | Via News | ViaNews Market